Pharma Journalist -

Codexis, Inc. announces the signing of a CodeEvolver platform agreement with Novartis. Under the terms of the agreement, Codexis has granted a non-exclusive license to its proprietary…
Read More...

ProBioGen AG, a premier German service & technology provider for complex biologics and Vaccitech, Ltd., a spin-out company from the University of Oxford’s Jenner Institute, one of…
Read More...

Adaptimmune Therapeutics and Alpine Immune Sciences announced a collaboration and license agreement to develop next-generation SPEAR T-cell products which incorporate Alpine’s secreted…
Read More...

Lyophilization Services of New England (LSNE), a leading contract development and manufacturing organization (CDMO) specializing in pharmaceuticals and medical devices, announced that…
Read More...

TraceLink Inc. announced the acceptance of its participation in the Food and Drug Administration (FDA) Pilot Project Program under the Drug Supply Chain Security Act (DSCSA).…
Read More...

Chiasma, Inc. and Lonza announced that the companies have entered into a commercial supply agreement for Chiasma’s oral somatostatin analog candidate, conditionally trade named…
Read More...

Zymeworks Inc. announced that it has entered into a licensing agreement that grants Iconic Therapeutics, Inc. (Iconic) non-exclusive rights to Zymeworks’ proprietary ZymeLink…
Read More...

Hoth Therapeutics, announced that the company has signed a term sheet with Zylö Therapeutics Inc (Zylö) to co-develop a new treatment for patients suffering from Cutaneous Lupus…
Read More...

AbbVie announced that it has resolved U.S. HUMIRA (adalimumab) litigation with Boehringer Ingelheim (BI). Under the terms of the resolution, AbbVie will grant BI a non-exclusive license…
Read More...

SMi reports: Registration is now open for the HPAPI USA conference, taking place in Boston on the 21st - 22nd October 2019. The HPAPI global market is growing at an ever-increasing…
Read More...